Medartis Holding AG
Research Medartis Holding AG (1RU) on Bullrun: market cap EUR 1.19B, P/E 74.6. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker1RU
- ExchangeF
- CountrySwitzerland
- SectorHealthcare
- IndustryMedical Devices
- CurrencyEUR
- Market capEUR 1.19B
- P/E74.6
- Financial periodFY2025
- RevenueCHF 269.26M
- Revenue growth19.8%
- Net incomeCHF 8.35M
- Free cash flowCHF 9.34M
- Gross margin75.9%
Valuation Snapshot
latest market cap is EUR 1.19B; P/E is 74.6.
Peer valuation comparison
Latest P/E is 74.61x versus a Healthcare sector median of 24.46x (205.0% above).
Latest P/E is 74.61x versus a Switzerland median of 20.32x (267.2% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CHF 269.26M | CHF 8.35M | CHF 9.34M | 75.9% | 0.67 | CHF 32.97M | CHF 157.72M | CHF 275.87M |
| FY2024 | CHF 224.83M | CHF 3.53M | CHF 20.98M | 79.5% | 0.28 | CHF 138.69M | CHF 120.77M | CHF 269.65M |
| FY2023 | CHF 212.01M | CHF 619.00K | CHF 1.17M | 79.0% | 0.05 | CHF 25.20M | CHF 26.92M | CHF 254.96M |
| FY2022 | CHF 182.82M | -CHF 5.78M | -CHF 22.72M | 81.8% | -0.49 | CHF 20.61M | CHF 27.49M | CHF 237.78M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-27 | EUR 1.19B | 74.6 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About Medartis Holding AG
Medartis Holding AG, a medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide. The company's medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Medartis Holding AG's market cap?
Medartis Holding AG's market capitalization is EUR 1.19B.
What is Medartis Holding AG's P/E ratio?
Medartis Holding AG's price-to-earnings (P/E) ratio is 74.6.
What does Medartis Holding AG do?
Medartis Holding AG, a medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide. The company's medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. It provides products for the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for upper and lower extremities, mandible, midface, orthognathic under the APTUS and MODUS names, as well as CMX services through web portal, and kerimedical products.